Publications

Title	Date	PC3I Authors	Journal
Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study	February 23, 2023	PC3I Authors Ronac Mamtani	BJUI Compass
Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval	February 23, 2023	PC3I Authors Ramy Sedhom; Ronac Mamtani	JAMA Oncology
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis	March 2, 2023	PC3I Authors Ronac Mamtani	Journal of Cancer Research & Clinical Oncology
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90	March 19, 2023	PC3I Authors Ronac Mamtani; Melina Marmarelis	Clinical Lung Cancer
Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer	April 14, 2023	PC3I Authors Ronac Mamtani	JAMA Network Open
Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation	May 8, 2023	PC3I Authors Ronac Mamtani	Epidemiology
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer	June 4, 2023	PC3I Authors Charu Aggarwal; Melina Marmarelis; Ronac Mamtani	JAMA Oncology
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens	July 14, 2023	PC3I Authors Charu Aggarwal; Christopher A. D’Avella; Ronac Mamtani; Melina Marmarelis	Clinical Lung Cancer
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma	September 4, 2023	PC3I Authors Ronac Mamtani	Cancer Investigation
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial	October 2, 2023	PC3I Authors Ronac Mamtani	Nature Medicine
Comparing survival in trial- versus routine-care advanced urothelial cancer patients on immune checkpoint blockade	April 29, 2024	PC3I Authors Lucy Wang; Ronac Mamtani	Pharmacoepidemiology and Drug Safety
Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma	October 18, 2023	PC3I Authors Ronac Mamtani	Frontiers in Oncology
Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer	March 19, 2024	PC3I Authors Ronac Mamtani	Urologic Oncology
The association between telemedicine, advance care planning, and unplanned hospitalizations among high-risk patients with cancer	November 21, 2023	PC3I Authors Peter Gabriel; Ronac Mamtani	Cancer
A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes	January 20, 2021	PC3I Authors Ronac Mamtani	European Journal of Gastroenterology & Hepatology
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival	November 27, 2023	PC3I Authors Ronac Mamtani	JAMA Network Open
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy	June 16, 2021	PC3I Authors Peter Gabriel; Ronac Mamtani	JCO Oncology Practice
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial	January 19, 2024	PC3I Authors Ronac Mamtani	Nature Medicine
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis	September 22, 2021	PC3I Authors Ronac Mamtani	Arthritis Care and Research (Hoboken)